Cardiorespiratory fitness and the metabolic syndrome: Roles of inflammation and abdominal obesity

PLoS ONE

Volumn 13, Issue 3, 2018, Pages

  Wedell Neergaard, Anne Sophie ^a   Krogh Madsen, Rikke ^a   Petersen, Gitte Lindved ^a   Hansen, Åse Marie ^a,b   Pedersen, Bente Klarlund ^a   Lund, Rikke ^a   Bruunsgaard, Helle ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; TRIACYLGLYCEROL; AUTACOID; BIOLOGICAL MARKER;

ABDOMINAL OBESITY; ADULT; AGE; ALCOHOL CONSUMPTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOMETABOLIC RISK; CARDIORESPIRATORY FITNESS; COHORT ANALYSIS; CONTROLLED STUDY; DANISH CITIZEN; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RISK REDUCTION; SCORING SYSTEM; SEX; SMOKING; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO; BODY COMPOSITION; COMPLICATION; KINESIOTHERAPY; METABOLISM; RISK FACTOR;

BIOMARKERS; BODY COMPOSITION; CARDIORESPIRATORY FITNESS; EXERCISE THERAPY; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; METABOLIC SYNDROME; MIDDLE AGED; OBESITY, ABDOMINAL; RISK FACTORS;

EID: 85044731291     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0194991     Document Type: Article

References (72)

1. Mathers C, Gretchen S, Mascarenhas M. Global Health Risks: Mortality and burden of disease attributable to selected major risks. WHO Library Cataloguing-in-Publication Data. 2009. https://doi.org/10.2471/BLT.09.070565
2. Olsen R, Krogh-Madsen R, Thomsen C, Booth F, Pedersen B. Metabolic Responses to Reduced Daily Steps in Healthy Nonexercising Men. JAMA. 2008;Mar 19: 1261–3.
3. Abramson JL, Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med. 2002; 162: 1286–1292. PMID: 12038947
4. Albert MA, Glynn RJ, Ridker PM. Effect of physical activity on serum C-reactive protein. Am J Cardiol. 2004; 93: 221–225. PMID: 14715354
5. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur studies of successful aging. J Am Geriatr Soc. 2003; 51: 1125–1130. PMID: 12890077
6. Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2014; 2: 1143–1211.
7. Pedersen BK, Saltin B. Exercise as medicine–evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sport. 2015; 25: 1–72.
8. Carnethon MR. Physical Activity and Cardiovascular Disease: How Much is Enough? Am J Lifestyle Med. 2009; 3: 44–49.
9. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint position statement. Diabetes Care. 2010; 33: 147–67.
10. Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Invest. 2017; 47: 600–611. https://doi.org/10.1111/eci.12781 PMID: 28722106
11. Karstoft K, Pedersen BK. Exercise and type 2 diabetes: focus on metabolism and inflammation. Immunol Cell Biol. Nature Publishing Group; 2015; 94: 146–150. https://doi.org/10.1038/icb.2015.101 PMID: 26568029
12. Alberti KGMM Eckel RH, Grundy SM Zimmet PZ, Cleeman JI Donato KA, et al. Harmonizing the metabolic syndrome. A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International. 2009; 1640–1645.
13. Koene RJ, Prizment AE, Blaes A, Konety SH. Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation. 2016; 133: 1104–1114. https://doi.org/10.1161/CIRCULATIONAHA.115.020406PMID: 26976915
14. Asghar A, Sheikh N. Role of immune cells in obesity induced low grade inflammation and insulin resistance. Cell Immunol. 2017; 315: 18–26. https://doi.org/10.1016/j.cellimm.2017.03.001 PMID: 28285710
15. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Geronology. 2004; 39: 687–699.
16. Benatti FB, Pedersen BK. Exercise as an anti-inflammatory therapy for rheumatic diseases—myokine regulation. Nat Rev Rheumatol. Nature Publishing Group; 2014; 11: 86–97.
17. Mckellar GE, Mccarey DW, Sattar N, Mcinnes IB. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol. Nature Publishing Group; 2009; 6: 410–417. https://doi.org/10.1038/nrcardio.2009.57 PMID: 19421244
18. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017; 1–13.
19. Zand H, Morshedzadeh N, Naghashian F. Signaling pathways linking inflammation to insulin resistance. Diabetes Metab Syndr Clin Res Rev. Diabetes India; 2017; 3: 1871–4021.
20. Hayashino Y, Jackson J, Hirata T, Fukumori N, Nakamura F, Fukuhara S, et al. Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Metabolism. Elsevier Inc.; 2014; 63: 431–440. https://doi.org/10.1016/j.metabol.2013.08.018 PMID: 24355625
21. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Hematop growth factors. 2001; 8: 131–136.
22. Slaats J, Oever J, Veerdonk FL Van De, Netea MG. IL-1 β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections. PLOS Pathog. 2016; 12: 1–13.
23. Blake GJ, Ridker PM. Novel Clinical Markers of Vascular Wall Inflammation. Circ Res. 2001; 89: 763–771. PMID: 11679405
24. Steensberg A, Fischer CP, Keller C, Møller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab. 2003; 285: 433–7.
25. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008; 226: 205–218. https://doi.org/10.1111/j.1600-065X.2008.00706.x PMID: 19161426
26. Tilg H, Moschen AR. Inflammatory Mechanisms in the Regulation of Insulin Resistance. Mol Med. 2008; 14: 222–231. https://doi.org/10.2119/2007-00119.Tilg PMID: 18235842
27. Trøseid M, Seljeflot I, Arnesen H. The role of interleukin-18 in the metabolic syndrome. Cardiovasc Dia-betol. 2010; 9: 1–8. https://doi.org/10.1186/1475-2840-9-1
28. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001; 12: 53–72. PMID: 11312119
29. Ilhan F, Sevgi Tas K. Atherosclerosis and the role of immune cells. World J Clin Cases. 2015; 3: 345–353. https://doi.org/10.12998/wjcc.v3.i4.345 PMID: 25879006
30. Wensveen FM, Valenti S, Sestan M, Wensveen TT, Polic B. The “Big Bang” in obese fat: Events initiating obesity-induced adipose tissue inflammation. Eur J Immunol. 2015; 45: 2446–2456. https://doi.org/10.1002/eji.201545502 PMID: 26220361
31. Leon MLA, Zuckerman SH. Gamma interferon: a central mediator in atherosclerosis. Inflamm Res. 2005; 54: 395–411. https://doi.org/10.1007/s00011-005-1377-2 PMID: 16283107
32. Cottam DR, Mattar SG, Barinas-mitchell E, Eid G, Kuller L, Kelley DE, et al. The Chronic Inflammatory Hypothesis for the Morbidity Associated with Morbid Obesity: Implications and Effects of Weight Loss. Obes Surg. 2004; 14: 589–600. https://doi.org/10.1381/096089204323093345 PMID: 15186624
33. Ibrahim MM. Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev. 2010; 11: 11–8. https://doi.org/10.1111/j.1467-789X.2009.00623.x PMID: 19656312
34. Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F. The concept of normal weight obesity. Prog Cardiovasc Dis. Elsevier Inc.; 2014; 56: 426–33. https://doi.org/10.1016/j.pcad.2013.10.003PMID: 24438734
35. Wajchenberg BL. Subcutaneous and Visceral Adipose Tissue: their relation to the metabolic syndrome. Endocr Rev. 2000; 21: 697–738. https://doi.org/10.1210/edrv.21.6.0415 PMID: 11133069
36. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat 1–3. Am J Clin Nutr. 2002; 75: 683–8. PMID: 11916754
37. Goh LGH, Dhaliwal SS, Welborn TA, Lee AH, Della PR. Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: a cross-sectional study. BMJ Open. 2014; 4: 1–9.
38. Lee CMY, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. 2008; 61: 646–653. https://doi.org/10.1016/j.jclinepi.2007.08.012 PMID: 18359190
39. Peter I, Papandonatos GD, Belalcazar LM, Yang Y, Erar B, Jakicic JM, et al. Genetic Modifiers of Cardiorespiratory Fitness Response to Lifestyle Intervention. Med Sci Sport Exerc. 2014; 46: 302–311.
40. Foster C, Hillsdon M, Thorogood M, Kaur A, Wedatilake T. Interventions for promoting physical activity Charles. Cochrane Database Syst Rev. 2014; 1–90.
41. Avlund K, Osler M, Mortensen EL, Christensen U, Bruunsgaard H, Holm-Pedersen P, et al. Copenhagen Aging and Midlife Biobank (CAMB): An Introduction. J Aging Health. 2014; 26: 5–20. https://doi.org/10.1177/0898264313509277 PMID: 24584257
42. Astrand P, Ryhming I. A Nomogram for Calculation of Aerobic Capacity (Physical Fitness) From Pulse Rate During Submaximal Work. J Appl Physiol. 1954;Sept.: 218–21. https://doi.org/10.1152/jappl.1954.7.2.218 PMID: 13211501
43. Åstrand I. Aerobic work capacity in men and women with special reference to age. Acta Physiol Scand. 1960; 49: 1–92. https://doi.org/10.1111/j.1748-1716.1960.tb01922.x PMID: 13801648
44. Onat A, Avci G, Barlan M, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes. 2004; 28: 1018–1025.
45. Garnett SP, Baur LA, Cowell CT. Waist-to-height ratio: a simple option for determining excess central adiposity in young people. Int J Obes. 2008; 32: 1028–1030.
46. Ashwell M, Cole TJ, Dixon AK. Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography. Br Med J. 1985; 290: 1692–1694.
47. Shoji K, Maeda K, Nakamura T, Funahashi T, Matsuzawaa Y, Shimomura I. Measurement of visceral fat by abdominal bioelectrical impedance analysis is beneficial in medical checkup. Obes Res Clin Pract. 2008; 2: 269–275.
48. Said HW El, Mohamed OM, Said TW El, Serwi AB El. Central obesity and risks of cardiovascular events and mortality in prevalent hemodialysis patients. Int Urol Nephrol. Springer Netherlands; 2017; 49: 1251–1260. https://doi.org/10.1007/s11255-017-1568-0 PMID: 28315007
49. Hansen ÅM, Lund R, Bruunsgaard H, Rod NH, Garde AH, Molbo D, et al. Social gradient in allostatic load among Danish men and women in late midlife. J Aging Health. 2014; 26: 72–87. https://doi.org/10.1177/0898264313508187 PMID: 24584261
50. Kim H, Lee S, Suh S, Kim JH, Lee MK, Park H. The relationship between estimated average glucose and fasting plasma glucose. Clin Chem Lab Med. 2013; 51: 2195–2200. https://doi.org/10.1515/cclm-2013-0045 PMID: 24057595
51. Pearson T a. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107: 499–511. PMID: 12551878
52. Christensen U, Krølner R, Nilsson CJ, Lyngbye PW, Hougaard CØ, Thielen K, et al. Addressing Social Inequality in Aging by the Danish Occupational Social Class Measurement. J Aging Health. 2014; 26: 106–127. https://doi.org/10.1177/0898264314522894 PMID: 24584263
53. https://stats.idre.ucla.edu/other/mult-pkg/faq/general/faqhow-do-i-interpret-a-regression-model-whensome-variables-are-log-transformed/ [Internet].
54. Church TS, Barlow CE, Earnest CP, Kampert JB, Priest EL, Blair SN. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol. 2002; 22: 1869–1876. PMID: 12426218
55. Williams MJ a, Milne BJ, Hancox RJ, Poulton R. C-reactive protein and cardiorespiratory fitness in young adults. Eur J Cardiovasc Prev Rehabil. 2005; 12: 216–220. PMID: 15942418
56. Aronson D, Sheikh-Ahmad M, Avizohar O, Kerner A, Sella R, Bartha P, et al. C-Reactive protein is inversely related to physical fitness in middle-aged subjects. Atherosclerosis. 2004; 176: 173–179. https://doi.org/10.1016/j.atherosclerosis.2004.04.025 PMID: 15306191
57. Knudsen SH, Hansen LS, Pedersen M, Dejgaard T, Hansen J, Hall G Van, et al. Changes in insulin sensitivity precede changes in body composition during 14 days of step reduction combined with overfeeding in healthy young men. J Appl Physiol. 2012; 113: 7–15. https://doi.org/10.1152/japplphysiol.00189. 2011 PMID: 22556394
58. Krogh-Madsen R, Pedersen M, Solomon TP, Knudsen SH, Hansen LS, Karstoft K, et al. Normal physical activity obliterates the deleterious effects of a high-caloric intake. J Appl Physiol. 2014; 116: 231–239. https://doi.org/10.1152/japplphysiol.00155.2013 PMID: 24201706
59. Charles A. Dinarello. The interleukin-1 family: 10 years of discovery. FASEB J. 2017; 8: 1314–1325.
60. Chan CS, Ming-lum A, Golds GB, Lee SJ, Anderson RJ, Mui AL. Interleukin-10 Inhibits Lipopolysaccharide-induced Tumor Necrosis Factor-alpha Translation through a SHIP1-dependent Pathway. J Biol Chem. 2012; 287: 38020–38027. https://doi.org/10.1074/jbc.M112.348599 PMID: 22955274
61. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-a production in humans. FASEB J. 2003; 17: 884–6. https://doi.org/10.1096/fj.02-0670fje PMID: 12626436
62. Ridker PM, Buring JE, Cook NR, Rifai N. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events. Clin Investig Reports. 2003; 107: 391–397.
63. Lee W, Park J, Noh S, Rhee E, Sung K, Kim B, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol. 2004; 97: 101–106. https://doi.org/10.1016/j.ijcard.2003.08.016 PMID: 15336815
64. Rana JS, Nasir K, Santos RD, Roguin A, Orakzai SH, Carvalho JAM, et al. Increased level of cardiorespiratory fitness blunts the inflammatory response in metabolic syndrome. 2006; 110: 224–230. https://doi.org/10.1016/j.ijcard.2005.08.040 PMID: 16290227
65. Wu Z, Huang Z, Jin W, Rimm EB, Lichtenstein AH, Kris-etherton PM. Peripheral Inflammatory Biomark-ers for Myocardial Infarction Risk: A Prospective Community-Based Study. 2017; 672: 663–672.
66. Turhan H, Yetkin O. The impact of cardiorespiratory fitness on inflammatory markers in patients with metabolic syndrome. 2006; 113: 2004–2005.
67. Zacho J, Tybjærg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease. N Engl J Med. 2008; 359: 1897–1908. https://doi.org/10.1056/NEJMoa0707402 PMID: 18971492
68. C reactive Protein Coronary Heart Disease Genetics Collaboration. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 2011; 342: 1–8.
69. Ridker PM, Macfadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017; 6736: 1–10.
70. Landi F, Zuccalri G, Gambassi G, Incalzi A, Manigrasso L, Pagano F. Body Mass Index and Mortality Among Older People Living in the Community. J Am Geriatr Soc. 1999; 47: 1072–1076. PMID: 10484248
71. Eng JJ, Dawson AS, Chu KS. Submaximal Exercise in Persons With Stroke: Test-Retest Reliability and Concurrent Validity With Maximal Oxygen Consumption. Arch Phys Med Rehabil. 2004; 85: 10–15.
72. Mally K, Trentmann J, Heller M, Dittmar M. Reliability and accuracy of segmental bioelectrical impedance analysis for assessing muscle and fat mass in older Europeans: a comparison with dual-energy X-ray absorptiometry. Eur J Appl Physiol. 2011; 111: 1879–1887. https://doi.org/10.1007/s00421-010-1795-x PMID: 21234595